Quotes of All Topics . Occasions . Authors
They're just beginning to change - Drug companies.
And there are lots of drug companies that are working on cure or medicine.
One problem I have with drug companies is that they don't make all their data public.
Medicare should be allowed to negotiate with drug companies for lower prices on prescriptions.
Competition leads both drug companies and private regulators to be trustworthy. If they are not trustworthy, they die.
In general, drug companies are reasonably good at developing new treatments, and there's also a lot of good in the industry.
We have taken on the health insurance industry, we have taken on the drug companies, instituting programs to lower the cost of prescription drugs.
If Americans could legally access prescription drugs outside the United States, then drug companies would be forced to re-evaluate their pricing strategy.
Democrats believe we must have comprehensive health care reform that includes giving the federal government authority to negotiate lower prices with drug companies.
Would-be drug companies must either produce medicines that stand up to federal scrutiny, demonstrate that their data has value to other companies, or go out of business.
New Hampshire state government is a big customer for prescription drug companies. Just as businesses do, we should take advantage of the bargaining power we have as a big customer.
While I support granting drug companies patents to recover their investment and encourage innovation, companies that take advantage of this goodwill to build a monopoly must be stopped.
Here in Maine, we've expanded Medicaid, put protections in place for seniors and people with pre-existing conditions, cracked down on big drug companies and protected reproductive rights.
If Congress continues to sit on its hands, and the drug companies continue to stash cash in their stockings, Americans will be forever bound in the Jacob Marley-like chains of high prices.
We don't argue if drug companies create drugs that can cure humans and charge lots of money for them, even though we all have these diseases. It will be pretty hard to make a different argument for genes.
It is incomprehensible that drug companies still get away with charging Americans twice as much, or more, than citizens of Canada or Europe for the exact same drugs manufactured by the exact same companies.
I'm a champion for personal differences. I have no sympathy for drug companies that can't figure out how to make personalized medicine. We could generalize that to 'All society should be much more personalized.'
Nowadays, my mood ungoverned, I'm free to think the most outrageous things, such as: might it not be a good idea to insist that drug companies give their preparations names that tell the user what they really do?
If you want quality service, you have to pay for it. You don't buy into waste. I have great misgivings about the amount of advertising that we see in the health care field, some by hospitals, a lot by drug companies.
The public relies on the advice of doctors and leading researchers. The public has a right to know about financial relationships between those doctors and the drug companies who make the pharmaceuticals prescribed by doctors.
There is actually quite a lot of crossover between the quacks and drug companies. They use the same tricks and tactics to bamboozle people into buying their pills, but drug firms can afford to use slightly more sophisticated versions.
Drug companies say they need to charge ever-higher prices to cover their research costs, but they spend far less on research and development than they do on marketing and administration, and afterwards they actually keep more in profits.
My priorities are a fair trade policy in this country, increasing the minimum wage, going after the drug companies for the way that they charge and their whole pricing structure that have put absolutely amazing drugs out of reach for so many Americans.
When I was in the Maine Senate and proposed Maine RX - a plan to lower prescription drug costs by forcing the pharmaceutical companies to negotiate - I was told by many people that it was too big an idea, and we couldn't overcome opposition from the drug companies.
Why have we settled for a medical system that allows cancer to be recast as a chronic and tolerable disease rather than one we should try to prevent? Why do so many scientists at the nation's drug companies and universities turn their backs on the possibility of prevention?
A lot of medicines are not there to cure diseases. That's fine - drugs that keep people alive who wouldn't otherwise be alive are useful. What I object to is the drug companies' advertising, which you see everywhere in the U.S., which claims that they are curing diseases when they're not.
Here's where the insurance companies really fail us. They over-pay hospitals, specialists and drug companies and then raise premiums to cover the costs. Further, when they pay hospitals 115% of what it should cost to care for a patient, they are paying for inefficiency that can be dangerous.
As MBA professors endlessly tell their students, companies do best when they stick to what they do well. There's a reason Apple doesn't make blenders. There's a reason Haagen-Dazs doesn't sell meat. And there's a reason drug companies should focus on saving and improving lives - not jeopardizing them.